vs
Side-by-side financial comparison of Agilent Technologies (A) and Ovintiv Inc. (OVV). Click either name above to swap in a different company.
Ovintiv Inc. is the larger business by last-quarter revenue ($2.1B vs $1.8B, roughly 1.1× Agilent Technologies). Ovintiv Inc. runs the higher net margin — 46.1% vs 17.0%, a 29.1% gap on every dollar of revenue. On growth, Agilent Technologies posted the faster year-over-year revenue change (7.0% vs -6.0%). Ovintiv Inc. produced more free cash flow last quarter ($489.0M vs $175.0M). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs -7.2%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Ovintiv Inc. is a U.S. petroleum company based in Denver. The company was formed in 2020 through a restructuring of its Canadian predecessor, Encana.
A vs OVV — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $2.1B |
| Net Profit | $305.0M | $946.0M |
| Gross Margin | 52.6% | — |
| Operating Margin | 19.6% | 21.2% |
| Net Margin | 17.0% | 46.1% |
| Revenue YoY | 7.0% | -6.0% |
| Net Profit YoY | -4.1% | 1676.7% |
| EPS (diluted) | $1.07 | $3.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $1.7B | $2.0B | ||
| Q2 25 | $1.7B | $2.2B | ||
| Q1 25 | $1.7B | $2.4B | ||
| Q4 24 | $1.7B | $2.2B | ||
| Q3 24 | $1.6B | $2.2B | ||
| Q2 24 | $1.6B | $2.2B |
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $946.0M | ||
| Q3 25 | $336.0M | $148.0M | ||
| Q2 25 | $215.0M | $307.0M | ||
| Q1 25 | $318.0M | $-159.0M | ||
| Q4 24 | $351.0M | $-60.0M | ||
| Q3 24 | $282.0M | $507.0M | ||
| Q2 24 | $308.0M | $340.0M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 21.2% | ||
| Q3 25 | 20.7% | 13.5% | ||
| Q2 25 | 18.0% | 23.1% | ||
| Q1 25 | 22.4% | -3.7% | ||
| Q4 24 | 24.0% | 0.1% | ||
| Q3 24 | 21.1% | 24.2% | ||
| Q2 24 | 23.1% | 25.4% |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | 46.1% | ||
| Q3 25 | 19.3% | 7.3% | ||
| Q2 25 | 12.9% | 13.9% | ||
| Q1 25 | 18.9% | -6.7% | ||
| Q4 24 | 20.6% | -2.7% | ||
| Q3 24 | 17.9% | 23.3% | ||
| Q2 24 | 19.6% | 15.5% |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $3.64 | ||
| Q3 25 | $1.18 | $0.57 | ||
| Q2 25 | $0.75 | $1.18 | ||
| Q1 25 | $1.11 | $-0.61 | ||
| Q4 24 | $1.23 | $-0.22 | ||
| Q3 24 | $0.97 | $1.92 | ||
| Q2 24 | $1.05 | $1.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $280.0M |
| Total DebtLower is stronger | $3.0B | $5.2B |
| Stockholders' EquityBook value | $6.9B | $11.2B |
| Total Assets | $12.8B | $20.4B |
| Debt / EquityLower = less leverage | 0.44× | 0.46× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $280.0M | ||
| Q3 25 | $1.5B | $25.0M | ||
| Q2 25 | $1.5B | $20.0M | ||
| Q1 25 | $1.5B | $8.0M | ||
| Q4 24 | $1.3B | $42.0M | ||
| Q3 24 | $1.8B | $9.0M | ||
| Q2 24 | $1.7B | $8.0M |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $5.2B | ||
| Q3 25 | $3.4B | $5.2B | ||
| Q2 25 | $3.3B | $5.3B | ||
| Q1 25 | $3.3B | $5.5B | ||
| Q4 24 | $3.3B | $5.5B | ||
| Q3 24 | $2.1B | $5.9B | ||
| Q2 24 | $2.1B | $6.1B |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $11.2B | ||
| Q3 25 | $6.4B | $10.2B | ||
| Q2 25 | $6.1B | $10.4B | ||
| Q1 25 | $6.0B | $10.1B | ||
| Q4 24 | $5.9B | $10.3B | ||
| Q3 24 | $5.9B | $10.7B | ||
| Q2 24 | $6.2B | $10.3B |
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $20.4B | ||
| Q3 25 | $12.2B | $19.4B | ||
| Q2 25 | $12.2B | $19.7B | ||
| Q1 25 | $11.9B | $19.6B | ||
| Q4 24 | $11.8B | $19.3B | ||
| Q3 24 | $11.0B | $19.9B | ||
| Q2 24 | $10.9B | $19.8B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 0.46× | ||
| Q3 25 | 0.53× | 0.51× | ||
| Q2 25 | 0.55× | 0.51× | ||
| Q1 25 | 0.56× | 0.55× | ||
| Q4 24 | 0.57× | 0.53× | ||
| Q3 24 | 0.36× | 0.55× | ||
| Q2 24 | 0.34× | 0.59× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $954.0M |
| Free Cash FlowOCF − Capex | $175.0M | $489.0M |
| FCF MarginFCF / Revenue | 9.7% | 23.8% |
| Capex IntensityCapex / Revenue | 5.2% | 22.6% |
| Cash ConversionOCF / Net Profit | 0.88× | 1.01× |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | $1.5B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $954.0M | ||
| Q3 25 | $362.0M | $812.0M | ||
| Q2 25 | $221.0M | $1.0B | ||
| Q1 25 | $431.0M | $873.0M | ||
| Q4 24 | $481.0M | $1.0B | ||
| Q3 24 | $452.0M | $1.0B | ||
| Q2 24 | $333.0M | $1.0B |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $489.0M | ||
| Q3 25 | $259.0M | $268.0M | ||
| Q2 25 | $107.0M | $492.0M | ||
| Q1 25 | $334.0M | $256.0M | ||
| Q4 24 | $388.0M | $468.0M | ||
| Q3 24 | $360.0M | $484.0M | ||
| Q2 24 | $230.0M | $398.0M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 23.8% | ||
| Q3 25 | 14.9% | 13.3% | ||
| Q2 25 | 6.4% | 22.2% | ||
| Q1 25 | 19.9% | 10.8% | ||
| Q4 24 | 22.8% | 21.4% | ||
| Q3 24 | 22.8% | 22.2% | ||
| Q2 24 | 14.6% | 18.1% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 22.6% | ||
| Q3 25 | 5.9% | 26.9% | ||
| Q2 25 | 6.8% | 23.5% | ||
| Q1 25 | 5.8% | 26.0% | ||
| Q4 24 | 5.5% | 25.3% | ||
| Q3 24 | 5.8% | 24.7% | ||
| Q2 24 | 6.5% | 28.4% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 1.01× | ||
| Q3 25 | 1.08× | 5.49× | ||
| Q2 25 | 1.03× | 3.30× | ||
| Q1 25 | 1.36× | — | ||
| Q4 24 | 1.37× | — | ||
| Q3 24 | 1.60× | 2.02× | ||
| Q2 24 | 1.08× | 3.00× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
OVV
| Product And Service Revenue | $1.7B | 84% |
| Sales Of Purchased Product | $338.0M | 16% |
